[DNA methylation and non-small cell lung cancer].

scientific article

[DNA methylation and non-small cell lung cancer]. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3779/J.ISSN.1009-3419.2010.08.14
P932PMC publication ID6000552
P698PubMed publication ID20704826

P2093author name stringLongbang Chen
Youwei Zhang
P2860cites workEpigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppressionQ24291194
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3BQ24564757
Genetic unmasking of an epigenetically silenced microRNA in human cancer cellsQ28288806
Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancerQ28291502
Global methylation profiling of lung cancer identifies novel methylated genesQ28360366
DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an updateQ28386334
A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignanciesQ28469084
Epigenetic mechanisms in mammalsQ28749982
Epigenetics in cancerQ29547853
Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancerQ29615066
Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypesQ33366330
DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patientsQ33560360
High-throughput DNA methylation profiling using universal bead arraysQ34483135
DNA methylation markers and early recurrence in stage I lung cancerQ34761286
Application of a methylation gene panel by quantitative PCR for lung cancersQ36047712
Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinomaQ36391746
High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancerQ36423456
Methylation patterns and chemosensitivity in NSCLC.Q36680930
DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinomaQ36785953
Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancerQ36791714
Getting to the root of miRNA-mediated gene silencingQ37055551
Cancer epigenomics: implications of DNA methylation in personalized cancer therapyQ37399404
Interplay between DNA methylation, histone modification and chromatin remodeling in stem cells and during developmentQ37468760
Lung cancer: from single-gene methylation to methylome profiling.Q37680724
IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.Q38347818
Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphomaQ39336768
The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancerQ39718239
Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancerQ39735773
Aberrant methylation of ADAMTS1 in non-small cell lung cancerQ39913233
Microarray analysis of promoter methylation in lung cancers.Q40325370
Methylation assay for the diagnosis of lung cancer on bronchial aspirates: a cohort studyQ40353010
DNA methylation profiles of lung tumorsQ44239218
Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancerQ44936616
MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cellsQ47591519
Gene promoter methylation in plasma and sputum increases with lung cancer riskQ47726867
Cytosine methylation profiles as a molecular marker in non-small cell lung cancer.Q51928710
Improving dimensionality reduction with spectral gradient descentQ51966053
Transcriptional inactivation of secreted frizzled-related protein 1 by promoter hypermethylation as a potential biomarker for non-small cell lung cancerQ53300465
Epigenetic inactivation of retinoid X receptor genes in non-small cell lung cancer and the relationship with clinicopathologic featuresQ53302308
miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancerQ53306726
Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasmaQ53527046
Identification of epigenetic aberrant promoter methylation of RASSF1A in serum DNA and its clinicopathological significance in lung cancerQ54559029
Mutational and Epigenetic Evidence for Independent Pathways for Lung Adenocarcinomas Arising in Smokers and Never SmokersQ57918851
Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancerQ74339046
p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancerQ78632829
Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancerQ79451527
Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabineQ79464414
DNA methylation and cancerQ81002014
Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohortQ82843914
Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancerQ84011209
Aberrant promoter methylation of FBLN-3 gene and clinicopathological significance in non-small cell lung carcinomaQ84901350
P433issue8
P407language of work or nameChineseQ7850
P921main subjectDNA methylationQ874745
P304page(s)821-826
P577publication date2010-08-01
P13046publication type of scholarly workreview articleQ7318358
P1433published inChinese Journal of Lung CancerQ26842043
P1476title[DNA methylation and non-small cell lung cancer].
P478volume13

Reverse relations

Q54381818DNA methylation of tumor suppressor genes located on chromosome 3p in non-small cell lung cancercites workP2860